Our Divisions at a Glance

Sartorius is a globally operating company with over 6,200 employees worldwide and subsidiaries based in more than 30 countries. Our business is subdivided into two divisions: Bioprocess Solutions offers integrated solutions for biopharmaceutical manufacture, and Lab Products & Services provides instruments, consumables and services for laboratories. We report on the business development of the two divisions starting here, and provide insights into their strategies here.

Bioprocess Solutions

Bioprocess Solutions focuses on bioprocess business with pharmaceutical customers. With its extensive product portfolio, the division helps customers to manufacture medications and vaccines safely and efficiently. Its major goal is to optimize pharmaceutical production processes, primarily by increasing the deployment of single-use products and solutions. The division is a global leader in filtration, fermentation, cell cultivation, membrane chromatography and in fluid management.

Key Figures

€ in millions 2015 2014 Δ in %
Sales revenue 809.2 615.6 20.91)
Order intake 869.9 652.7 22.81)
Underlying EBITDA 214.5 145.6 47.3
as a % of sales
26.5 23.7
Employees2) 4,030 3,527 14.3

1) In constant currencies

2) As of Dec. 31

Lab Products & Services

With its premium laboratory instruments, consumables and excellent services, the Lab Products & Services Division is positioned as a broad-based laboratory supplier. It concentrates on laboratories of both the research and quality assurance units in pharmaceutical and biopharmaceutical companies and on academic research institutes. The division serves further customers in the chemical and food industries. Its Sartorius-brand laboratory products enable reliable and efficient analyses in the lab, helping to drive and accelerate scientific progress. The division is among the market leaders in laboratory balances, pipettes and lab consumables.

Key Figures

€ in millions 2015 2014 Δ in %
Sales revenue 305.5 275.5 5.01)
Order intake 302.8 276.5 3.71)
Underlying EBITDA 48.8 41.2 18.4
as a % of sales
16.0 15.0
Employees2) 2,155 2,084 3.4

1) In constant currencies

2) As of Dec. 31